FDA can­cels ODAC meet­ing this week as Se­cu­ra Bio pulls ac­cel­er­at­ed ap­proval

The FDA’s On­co­log­ic Drugs Ad­vi­so­ry Com­mit­tee has de­cid­ed to can­cel a planned meet­ing on Thurs­day to dis­cuss two can­cer drugs that pre­vi­ous­ly won ac­cel­er­at­ed ap­provals …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER